Research at University Health Network
 
Technology Transfer
Menu Level 3  
   
 
Daniel Winer, MD, FRCPC
Scientist, Toronto General Research Institute (TGRI)
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Keywords: diabetes, obesity, autoimmunity, insulin resistance, adipose tissue, cellular immunology, Inflammation 

Research Interests
The goal of our laboratory is to better understand how the immune system influences physiological processes and contributes to disease, with the aim of using this information to develop new translational diagnostics and therapeutics, including preventative vaccination strategies.

Inflammation and adaptive Immunity in insulin resistance and type 2 diabetes.

Our primary research focus is to elucidate immune mediated pathways governing obesity related insulin resistance. Obesity and its major complications, including insulin resistance, are a major global cause of morbidity and mortality, and have reached epidemic proportions. Evidence is mounting that a significant contributing cause of insulin resistance is chronic inflammation in visceral adipose tissue (VAT). This inflammation was initially thought to be driven solely by macrophages of the innate immune system attracted to dying adipocytes in fat. Recently, in collaboration with the Hospital for Sick Children and Stanford University, we have demonstrated that the adaptive immune system, including T cells, B cells and the antibodies they produce, play a significant and active role in regulating this process. This work has introduced a new " autoimmune" component to obesity related insulin resistance, and has led to new ways in thinking about metabolic disease. We continue to investigate immune mediated mechanisms in obesity and diabetes with the aim of translating our findings to help the many people afflicted by these diseases.

 
 
Selected Publications

  • Alonso MN et al. TH1, TH2, and TH17 cells instruct monocytes to differentiate into specialized dendritic cell subsets. Blood. [Epub Aug 2, 2011].

  • Winer D et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011 May; 17(5):610-7.

  • Winer S et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med. 2009 Aug; 15(8):921-9.

 
 
  Daniel Winer
Mailing Address
Primary Office
MaRS Centre
Toronto Medical Discovery Tower
10th Floor Room 352
101 College St.
Toronto, Ontario
Canada M5G 1L7

Primary Office
MaRS Centre
Toronto Medical Discovery Tower
10th floor Room 401
101 College St.
Toronto, Ontario
Canada M5G 1L7

 
Email

Phone Numbers
416-581-7533(Primary)

 

   
 
 
 
Home Researchers Facilities Support Services Programs Commercialization Ethics News About UHN Institutes OCI Techna TGRI TRI TWRI